4.0
18. Dez. 2024
Aktueller Mitarbeiter, mehr als 1 Jahr
Rahway, NJ
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Science drives MRL and there are many exceptional people here.
Kontras
Large company issues like strong hierarchy, silos, lack of individual accountability. Many employee had no other pharma experience, or it was decades ago, and that perpetuates the status quo while the rest of the industry is rapidly changing.